Table of Contents
Chapter 1. Global Antibiotic Drugs Market Executive Summary
1.1. Global Antibiotic Drugs Market Size & Forecast (2024-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Indication
1.3.3. By Route of Administration
1.3.4. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Antibiotic Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antibiotic Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Infectious Diseases
3.1.2. Growing Awareness and Access to Healthcare
3.1.3. R&D in Novel Antibiotics
3.2. Market Challenges
3.2.1. Antibiotic Resistance
3.2.2. High Cost of New Drug Development
3.3. Market Opportunities
3.3.1. Rising Geriatric Population
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Antibiotic Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Antibiotic Drugs Market Size & Forecasts by Drug Class 2024-2032
5.1. Segment Dashboard
5.2. Global Antibiotic Drugs Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Penicillins
5.2.2. Fluoroquinolones
5.2.3. Cephalosporins
5.2.4. Macrolides
5.2.5. Others
Chapter 6. Global Antibiotic Drugs Market Size & Forecasts by Indication 2024-2032
6.1. Segment Dashboard
6.2. Global Antibiotic Drugs Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Dermatological Infections
6.2.2. Respiratory Infections
6.2.3. Urinary Tract Infections
6.2.4. Ear Infections
6.2.5. Gastrointestinal Infections
6.2.6. Others
Chapter 7. Global Antibiotic Drugs Market Size & Forecasts by Route of Administration 2024-2032
7.1. Segment Dashboard
7.2. Global Antibiotic Drugs Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Oral
7.2.2. Parenteral
Chapter 8. Global Antibiotic Drugs Market Size & Forecasts by Distribution Channel 2024-2032
8.1. Segment Dashboard
8.2. Global Antibiotic Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Retail Pharmacies
8.2.2. Hospital Pharmacies
8.2.3. Online Pharmacies
Chapter 9. Global Antibiotic Drugs Market Size & Forecasts by Region 2024-2032
9.1. North America Antibiotic Drugs Market
9.1.1. U.S. Antibiotic Drugs Market
9.1.1.1. Drug Class breakdown size & forecasts, 2024-2032
9.1.1.2. Indication breakdown size & forecasts, 2024-2032
9.1.1.3. Route of Administration breakdown size & forecasts, 2024-2032
9.1.1.4. Distribution Channel breakdown size & forecasts, 2024-2032
9.1.2. Canada Antibiotic Drugs Market
9.2. Europe Antibiotic Drugs Market
9.2.1. U.K. Antibiotic Drugs Market
9.2.2. Germany Antibiotic Drugs Market
9.2.3. France Antibiotic Drugs Market
9.2.4. Spain Antibiotic Drugs Market
9.2.5. Italy Antibiotic Drugs Market
9.2.6. Rest of Europe Antibiotic Drugs Market
9.3. Asia-Pacific Antibiotic Drugs Market
9.3.1. China Antibiotic Drugs Market
9.3.2. India Antibiotic Drugs Market
9.3.3. Japan Antibiotic Drugs Market
9.3.4. Australia Antibiotic Drugs Market
9.3.5. South Korea Antibiotic Drugs Market
9.3.6. Rest of Asia Pacific Antibiotic Drugs Market
9.4. Latin America Antibiotic Drugs Market
9.4.1. Brazil Antibiotic Drugs Market
9.4.2. Mexico Antibiotic Drugs Market
9.4.3. Rest of Latin America Antibiotic Drugs Market
9.5. Middle East & Africa Antibiotic Drugs Market
9.5.1. Saudi Arabia Antibiotic Drugs Market
9.5.2. South Africa Antibiotic Drugs Market
9.5.3. Rest of Middle East & Africa Antibiotic Drugs Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Abbott Laboratories
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. AbbVie
10.3.3. F. Hoffmann-La Roche Ltd.
10.3.4. GlaxoSmithKline plc
10.3.5. Merck & Co. Inc.
10.3.6. Mylan N.V.
10.3.7. Novartis International AG (Sandoz)
10.3.8. Sanofi
10.3.9. Teva Pharmaceutical Industries Ltd.
10.3.10. Melinta Therapeutics
10.3.11. Pfizer Inc.
10.3.12. Basilea Pharmaceutica Ltd.
10.3.13. Tetraphase Pharmaceuticals
10.3.14. Paratek Pharmaceuticals, Inc.
10.3.15. Nabriva Therapeutics plc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes